Avience Biomedicals Ltd vs Kwick Forensic Solutions Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Avience Biomedicals Ltd is ₹ 240 as of 23 Oct 15:30 . The P/E Ratio of Avience Biomedicals Ltd is 0 as of March 2024 .The P/E Ratio of Kwick Forensic Solutions Ltd is 0 as of March 2024 . The Market Cap of Avience Biomedicals Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Kwick Forensic Solutions Ltd is ₹ 0 crore as of March 2024 . The Dividend Payout of Avience Biomedicals Ltd changed from 0 % on March 2022 to 0 % on March 2021 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Kwick Forensic Solutions Ltd changed from 0 % on March 2022 to 0 % on March 2021 . This represents a CAGR of 0.0% over 6 years .

About Avience Biomedicals Ltd

Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

About Kwick Forensic Solutions Ltd

Kwick Forensic Solutions Limited was initially incorporated as 'Kwick Soft Solutions Private Limited' as a Private Company on March 4, 2005 with the Registrar of Companies, Tamil Nadu.
Later, the name of the Company got changed from 'Kwick Soft Solutions Private Limited' to 'Kwick Integrated Forensic and Investigation Solutions Private Limited' on July 08, 2024 and again changed to 'Kwick Forensic Solutions Private Limited' on September 16, 2024.
Now, the Company has got status converted to Public Limited Company via fresh Certificate of Incorporation issued by the Central Processing Centre on April 29, 2025. Company provides end-to-end forensic products and services across four segments-Forensic Science & Physical Evidence Solutions, Mobile CSI Vehicles, Cyber & Digital Forensics, and DNA Forensics-together with a services line for liquor detection scanner with manpower support.

FAQs for the comparison of Avience Biomedicals Ltd and null

Which company has a larger market capitalization, Avience Biomedicals Ltd or Kwick Forensic Solutions Ltd?

Market cap of Avience Biomedicals Ltd is 131 Cr while Market cap of Kwick Forensic Solutions Ltd is 405 Cr

What are the key factors driving the stock performance of Avience Biomedicals Ltd and Kwick Forensic Solutions Ltd?

The stock performance of Avience Biomedicals Ltd and Kwick Forensic Solutions Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Avience Biomedicals Ltd and Kwick Forensic Solutions Ltd?

As of October 25, 2026, the Avience Biomedicals Ltd stock price is INR ₹240.0. On the other hand, Kwick Forensic Solutions Ltd stock price is INR ₹188.95.

How do dividend payouts of Avience Biomedicals Ltd and Kwick Forensic Solutions Ltd compare?

To compare the dividend payouts of Avience Biomedicals Ltd and Kwick Forensic Solutions Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.